Zentalis Pharmaceuticals, Inc.

SEC 4 · Filed

0002018766-26-000002Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Jan 8, 2026

Grant, award or other acquisition by Vultaggio Vincent

Security
Stock Option (Right to Buy)
Code
A
Shares
100,000
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-01-08",
  "direction": "A",
  "exercise_price": "2.84",
  "expiration": "2036-01-07",
  "footnotes": {
    "F1": "The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person\u0027s continued service with the Issuer."
  },
  "owners": [
    {
      "cik": "0002018766",
      "name": "Vultaggio Vincent",
      "roles": [
        "officer"
      ],
      "title": "PAO and PFO"
    }
  ],
  "ownership": "D",
  "post_shares": "100000",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Stock Option (Right to Buy)",
  "shares": "100000",
  "table": "II",
  "underlying_security": "Stock Option",
  "underlying_shares": "100000"
}